Data from Pharmawand - Curated by EPG Health - Date added 05 December 2017

Treatment of a HIV infected lung cancer patient with Opdivo (nivolumab) by physicians at the Pitie Salpetriere Hospital showed a huge decrease in the patient’s viral “reservoirs”— areas in the body that allow HIV to escape from antiretroviral treatments. The discovery could lead to a new method for dealing with viral reservoirs, which have proven to be one of the biggest hurdles to developing HIV cures and vaccines. These reservoirs contain latent HIV-infected cells that can reawaken at any time, making it impossible to eradicate the virus for good. The treatment was reported by a letter to the Annals of Oncology.

See-"Drastic decrease of the HIV reservoir in a patient treated with nivolumab for lung cancer"- A Guihot A -G Marcelin M -A Massiani A Samri C Soulié B Autran J -P Spano.- Annals of Oncology, mdx696,

Published: 01 December 2017.


You will need to login, to leave a comment. is not monitored for collection of adverse event reports. Any adverse events should be reported to your national reporting agency and/or the manufacturer.

Learning Zones

An Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease (COPD)

View highlights from recent congresses presented in new expert videos with leading physicians.

+ 7 more

Migraine Knowledge Centre

Migraine Knowledge Centre

The Migraine Knowledge Centre features latest research on the prevalence and impact of migraine, the proposed neurological basis of the condition (and how this is being translated into new and exciting drug therapies), as well as current patient care strategies collated from headache organisations worldwide.

Acute and Advanced Heart Failure

Acute and Advanced Heart Failure

What are the most effective treatments for acute heart failure? Can you define advanced heart failure? Discover here...

+ 3 more

Load more

Related Content